Thomson Medical Group Limited (SGX: A50)
0.0500
+0.0020 (4.17%)
Sep 12, 2024, 9:00 AM SGT
Thomson Medical Group Cash Flow Statement
Financials in millions SGD. Fiscal year is July - June.
Millions SGD. Fiscal year is Jul - Jun.
Fiscal Year | TTM | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 | 2019 - 2015 |
---|---|---|---|---|---|---|---|
Period Ending | Jun '24 Jun 30, 2024 | Jun '24 Jun 30, 2024 | Jun '23 Jun 30, 2023 | Jun '22 Jun 30, 2022 | Jun '21 Jun 30, 2021 | Jun '20 Jun 30, 2020 | 2019 - 2015 |
Net Income | 15.44 | 15.44 | 36.56 | 53.76 | 14.24 | -99.44 | Upgrade
|
Depreciation & Amortization | 25.43 | 25.43 | 20.02 | 17.58 | 17.61 | 18.25 | Upgrade
|
Other Amortization | 2.87 | 2.87 | 1.69 | 1.34 | 1.76 | 1.38 | Upgrade
|
Loss (Gain) From Sale of Assets | 0.11 | 0.11 | 0.14 | -0.02 | 0.19 | 0.84 | Upgrade
|
Asset Writedown & Restructuring Costs | -25.5 | -25.5 | 0.01 | 0.17 | 0.02 | 0.01 | Upgrade
|
Loss (Gain) on Equity Investments | 0.19 | 0.19 | 0.49 | - | - | - | Upgrade
|
Stock-Based Compensation | 0.56 | 0.56 | 0.21 | 0.07 | 0.07 | 0.07 | Upgrade
|
Provision & Write-off of Bad Debts | 0.07 | 0.07 | 1.4 | 0.15 | 0.41 | 0.39 | Upgrade
|
Other Operating Activities | 52.19 | 52.19 | 33.56 | 29.68 | 27.67 | 123.22 | Upgrade
|
Change in Accounts Receivable | 25.63 | 25.63 | -4.6 | -32.94 | -4.84 | 0.52 | Upgrade
|
Change in Inventory | 0.67 | 0.67 | -1.26 | -0.27 | 0.73 | -0.74 | Upgrade
|
Change in Accounts Payable | -14.31 | -14.31 | 0.38 | 23.28 | 3.42 | 10.76 | Upgrade
|
Operating Cash Flow | 83.35 | 83.35 | 88.59 | 92.8 | 61.25 | 55.25 | Upgrade
|
Operating Cash Flow Growth | -5.92% | -5.92% | -4.53% | 51.51% | 10.87% | -18.99% | Upgrade
|
Capital Expenditures | -26.86 | -26.86 | -11.21 | -27.75 | -37.29 | -56.65 | Upgrade
|
Sale of Property, Plant & Equipment | 0.34 | 0.34 | 0.09 | 0.05 | 0.06 | 0.19 | Upgrade
|
Cash Acquisitions | -459.97 | -459.97 | - | - | - | - | Upgrade
|
Sale (Purchase) of Intangibles | -3.5 | -3.5 | -1.58 | -0.37 | -0.34 | -0.36 | Upgrade
|
Investment in Securities | - | - | -0.69 | -1.36 | - | - | Upgrade
|
Investing Cash Flow | -489.99 | -489.99 | -13.39 | -29.44 | -37.57 | -56.81 | Upgrade
|
Long-Term Debt Issued | 557.09 | 557.09 | 366.1 | 23.53 | 254.26 | 423.87 | Upgrade
|
Total Debt Issued | 557.09 | 557.09 | 366.1 | 23.53 | 254.26 | 423.87 | Upgrade
|
Short-Term Debt Repaid | - | - | - | - | - | -4.81 | Upgrade
|
Long-Term Debt Repaid | -206.58 | -206.58 | -249.14 | -19.76 | -291.9 | -354.44 | Upgrade
|
Total Debt Repaid | -206.58 | -206.58 | -249.14 | -19.76 | -291.9 | -359.25 | Upgrade
|
Net Debt Issued (Repaid) | 350.52 | 350.52 | 116.96 | 3.77 | -37.64 | 64.62 | Upgrade
|
Issuance of Common Stock | - | - | - | 0.01 | - | - | Upgrade
|
Common Dividends Paid | -10.58 | -10.58 | - | - | - | - | Upgrade
|
Other Financing Activities | -58.62 | -58.62 | -32.33 | -23.29 | -21.18 | -31.16 | Upgrade
|
Financing Cash Flow | 281.33 | 281.33 | 54.22 | -23.48 | -58.82 | 33.46 | Upgrade
|
Foreign Exchange Rate Adjustments | -0.6 | -0.6 | -4.17 | -1.08 | -0.28 | 0.74 | Upgrade
|
Net Cash Flow | -125.92 | -125.92 | 125.26 | 38.81 | -35.42 | 32.64 | Upgrade
|
Free Cash Flow | 56.49 | 56.49 | 77.39 | 65.05 | 23.96 | -1.4 | Upgrade
|
Free Cash Flow Growth | -27.01% | -27.01% | 18.97% | 171.46% | - | - | Upgrade
|
Free Cash Flow Margin | 14.76% | 14.76% | 21.46% | 19.22% | 9.97% | -0.65% | Upgrade
|
Free Cash Flow Per Share | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | -0.00 | Upgrade
|
Cash Interest Paid | 49.73 | 49.73 | 31.11 | 22.11 | 22.25 | 24.05 | Upgrade
|
Cash Income Tax Paid | 14.51 | 14.51 | 14.78 | 8.31 | 6.54 | 6.6 | Upgrade
|
Levered Free Cash Flow | 3.29 | 3.29 | 42.17 | 30.92 | 9.18 | - | Upgrade
|
Unlevered Free Cash Flow | 34.67 | 34.67 | 60.59 | 44.62 | 22.53 | - | Upgrade
|
Change in Net Working Capital | 9.85 | 9.85 | -0.69 | 2.64 | -11.64 | - | Upgrade
|
Source: S&P Capital IQ. Standard template. Financial Sources.